Outpatient administration of liposomal daunorubicin and cytarabine (Vyxeos) in patients with secondary acute myeloid leukemia.
Publication/Presentation Date
11-1-2019
Volume
17
Issue
11
First Page
604
Last Page
606
ISSN
1543-0790
Published In/Presented At
Kasner M. T. (2019). Outpatient administration of liposomal daunorubicin and cytarabine (Vyxeos) in patients with secondary acute myeloid leukemia. Clinical advances in hematology & oncology : H&O, 17(11), 604–606.
Disciplines
Medicine and Health Sciences
PubMedID
31851160
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS